Over 15 CD39-Targeted Treatments in Clinical Trials, Market Opportunity Surges by 2025
CD39-Targeted Therapies Near Key Milestones, First Approval Projected by 2029Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "CD39 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market ...
The EMBO Journal23 小时
Boosting human immunology: harnessing the potential of immune organoids
Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...